TERM ID="NYU_TERM_1" STRING="HT-29" FREQUENCY=1 START=1478 END=1483 LEMMA="HT-29" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="ITGB6" FREQUENCY=1 START=331 END=336 LEMMA="ITGB6" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="ITGB6 expression level" FREQUENCY=1 START=1362 END=1384 LEMMA="ITGB6 EXPRESSION LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="ITGB6-positive cancer cells" FREQUENCY=1 START=621 END=648 LEMMA="ITGB6-POSITIVE CANCER CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="ITGB6-positive colon cancer cells" FREQUENCY=1 START=1219 END=1252 LEMMA="ITGB6-POSITIVE COLON CANCER CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="ITGB6-targeted" FREQUENCY=1 START=1151 END=1165 LEMMA="ITGB6-TARGETED" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="ITGB6-targeted immunoliposome internalization" FREQUENCY=1 START=1295 END=1340 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME INTERNALIZATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="ITGB6-targeted immunoliposomes" FREQUENCY=7 START=747 END=777 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_9" STRING="ITGB6-targeted immunoliposomes" FREQUENCY=7 START=999 END=1029 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_10" STRING="ITGB6-targeted immunoliposomes" FREQUENCY=7 START=1097 END=1127 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_11" STRING="ITGB6-targeted immunoliposomes" FREQUENCY=7 START=1406 END=1436 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_12" STRING="ITGB6-targeted immunoliposomes" FREQUENCY=7 START=1558 END=1588 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_13" STRING="ITGB6-targeted immunoliposomes" FREQUENCY=7 START=1721 END=1751 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_14" STRING="ITGB6-targeted immunoliposomes" FREQUENCY=7 START=1873 END=1903 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_15" STRING="ITGB6-targeted immunoliposomes internalization" FREQUENCY=1 START=854 END=900 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOMES INTERNALIZATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="Integrinβ6" FREQUENCY=1 START=319 END=329 LEMMA="INTEGRINΒ6" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="Integrinβ6-targeted immunoliposomes" FREQUENCY=1 START=0 END=35 LEMMA="INTEGRINΒ6-TARGETED IMMUNOLIPOSOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="PEGylated liposomes" FREQUENCY=1 START=703 END=722 LEMMA="PEGYLATED LIPOSOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="SW480β6 cells" FREQUENCY=1 START=1488 END=1501 LEMMA="SW480Β6 CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="addition" FREQUENCY=1 START=1039 END=1047 LEMMA="ADDITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="anticancer strategy" FREQUENCY=1 START=2037 END=2056 LEMMA="ANTICANCER STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="anticancer strategy for clinical therapy" FREQUENCY=1 START=2037 END=2077 LEMMA="CLINICAL THERAPY ANTICANCER STRATEGY" LEMMA_FREQUENCY=1 HEAD_TERM="anticancer strategy" HEAD_LEMMA="ANTICANCER STRATEGY"
TERM ID="NYU_TERM_23" STRING="antitumor efficiency" FREQUENCY=1 START=1073 END=1093 LEMMA="ANTITUMOR EFFICIENCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="antitumor efficiency of ITGB6-targeted immunoliposomes" FREQUENCY=1 START=1073 END=1127 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME ANTITUMOR EFFICIENCY" LEMMA_FREQUENCY=1 HEAD_TERM="antitumor efficiency" HEAD_LEMMA="ANTITUMOR EFFICIENCY"
TERM ID="NYU_TERM_25" STRING="biodistribution" FREQUENCY=1 START=1053 END=1068 LEMMA="BIODISTRIBUTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="cellular internalization" FREQUENCY=1 START=1191 END=1215 LEMMA="CELLULAR INTERNALIZATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="cellular surface" FREQUENCY=1 START=1388 END=1404 LEMMA="CELLULAR SURFACE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="chemotherapeutic efficacy" FREQUENCY=1 START=660 END=685 LEMMA="CHEMOTHERAPEUTIC EFFICACY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="chemotherapeutic resistance" FREQUENCY=1 START=468 END=495 LEMMA="CHEMOTHERAPEUTIC RESISTANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="clinical therapy" FREQUENCY=1 START=2061 END=2077 LEMMA="CLINICAL THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="colon carcinoma Adjuvant chemotherapy" FREQUENCY=1 START=109 END=146 LEMMA="COLON CARCINOMA ADJUVANT CHEMOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="colonic epithelia" FREQUENCY=1 START=364 END=381 LEMMA="COLONIC EPITHELIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="drug delivery" FREQUENCY=2 START=602 END=615 LEMMA="DRUG DELIVERY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_34" STRING="drug delivery" FREQUENCY=2 START=1953 END=1966 LEMMA="DRUG DELIVERY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_35" STRING="liposomes" FREQUENCY=3 START=1267 END=1276 LEMMA="LIPOSOME" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_36" STRING="liposomes" FREQUENCY=3 START=1673 END=1682 LEMMA="LIPOSOME" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_37" STRING="liposomes" FREQUENCY=3 START=1857 END=1866 LEMMA="LIPOSOME" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_38" STRING="mAbs" FREQUENCY=1 START=819 END=823 LEMMA="MONOCLONAL ANTIBODIES" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="metastasis" FREQUENCY=1 START=452 END=462 LEMMA="METASTASI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="monoclonal antibodies" FREQUENCY=2 START=796 END=817 LEMMA="MONOCLONAL ANTIBODY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_41" STRING="monoclonal antibodies" FREQUENCY=2 START=796 END=817 LEMMA="MONOCLONAL ANTIBODY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_42" STRING="normal epithelia" FREQUENCY=1 START=394 END=410 LEMMA="NORMAL EPITHELIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="therapeutic activity" FREQUENCY=1 START=1697 END=1717 LEMMA="THERAPEUTIC ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="therapeutic activity of ITGB6-targeted immunoliposomes" FREQUENCY=1 START=1697 END=1751 LEMMA="ITGB6-TARGETED IMMUNOLIPOSOME THERAPEUTIC ACTIVITY" LEMMA_FREQUENCY=1 HEAD_TERM="therapeutic activity" HEAD_LEMMA="THERAPEUTIC ACTIVITY"
TERM ID="NYU_TERM_45" STRING="therapeutic approaches" FREQUENCY=1 START=552 END=574 LEMMA="THERAPEUTIC APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="therapeutic efficacy" FREQUENCY=2 START=85 END=105 LEMMA="THERAPEUTIC EFFICACY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_47" STRING="therapeutic efficacy" FREQUENCY=2 START=253 END=273 LEMMA="THERAPEUTIC EFFICACY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_48" STRING="tumor weight" FREQUENCY=1 START=1822 END=1834 LEMMA="TUMOR WEIGHT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="tumor-specific drug delivery" FREQUENCY=1 START=44 END=72 LEMMA="TUMOR-SPECIFIC DRUG DELIVERY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="vivo" FREQUENCY=2 START=1145 END=1149 LEMMA="VIVO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_51" STRING="vivo" FREQUENCY=2 START=1687 END=1691 LEMMA="VIVO" LEMMA_FREQUENCY=2
